Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2021 | Future treatment landscape for colon cancer

Giacomo Bregni • 9 Apr 2021
AACR 2021
Colon Cancer Colorectal Cancer Gastrointestinal Cancer 5-fluorouracil Antibodies Oxaliplatin Panitumumab
FOxTROT

Giacomo Bregni, MD, Jules Bordet Institute, Brussels, Belgium, shares his views on how treatment strategies for colon and colorectal cancer will evolve over the next few years, highlighting results from the FOxTROT trial (NCT00647530) and the potential role of immune checkpoint inhibitors in the future. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

More from Giacomo Bregni

3:29
ctDNA and cfDNA : prognostic value in the neoadjuvant setting of colon cancer
Giacomo Bregni • 9 Apr 2021
1:53
REGINA: regorafenib, nivolumab and short-course radiotherapy for rectal cancer
Giacomo Bregni • 9 Apr 2021

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals